Finance

Lists
TBPH:NASDAQ
Theravance Biopharma Inc
$16.97
+0.30%
(+0.050) 1D
$16.97
0.00% (0.00)
After hours
Closed: Aug 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TBPH...
Open
$16.91
High
$16.99
Low
$16.91
Mkt. cap
881.06M
Avg. vol.
669.32K
Volume
405.44K
P/E ratio
16.83
52-wk high
$21.03
52-wk low
$12.78
EPS
$1.01
Beta
0.19
Shares outstanding
51.92M
No. of employees
90
Open
$16.91
High
$16.99
Low
$16.91
Mkt. cap
881.06M
Avg. vol.
669.32K
Volume
405.44K
P/E ratio
16.83
52-wk high
$21.03
52-wk low
$12.78
EPS
$1.01
Beta
0.19
Shares outstanding
51.92M
No. of employees
90
News stories
From web sources and news partners
About Theravance Biopharma Inc
CEO-
Employees90
Founded2013
Headquarters-
SectorPharmaceutical industry
Websitetheravance.com
Analyst ratings
Based on 3 analysts giving stock ratings to TBPH in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TBPH in the last 3 months.
Highest
Current $16.97
$17.00 (+0.18%)
Average
$17.00 (+0.18%)
Lowest
$17.00 (+0.18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Hold
Maintained
$17.00
+0.2%
08/11/2026
Julian Harrison
BTIG
Hold
Downgraded
-
-
06/29/2026
Debanjana Chatterjee
JonesTrading
Hold
Downgraded
$17.00
+0.2%
06/29/2026
Marc Frahm
TD Cowen
Hold
Reiterated
$15.00
-11.6%
05/08/2026
Mayank Mamtani
B. Riley Securities
Hold
Maintained
$17.00
+0.2%
04/07/2026
Trevor Allred
Oppenheimer
Hold
Downgraded
$13.67
-19.4%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.99M
45.89M
17.70M
20.73M
Cost of goods sold
8.11M
7.36M
5.83M
-
Cost of revenue
8.11M
7.36M
5.83M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.33M
18.52M
17.72M
14.18M
Operating expense
18.33M
18.52M
17.72M
14.18M
Total operating expenses
26.44M
25.88M
23.55M
18.89M
Operating income
-6.46M
20.01M
-5.85M
1.84M
Other non operating income
-
-75.14M
-
-
EBT including unusual items
-2.89M
73.07M
-6.47M
-4.79M
EBT excluding unusual items
-2.89M
-52.07M
-2.84M
-760.00K
Income tax expense
-6.50M
12.04M
-1.54M
1.11M
Effective tax rate
225.13%
16.48%
23.76%
-23.11%
Other operating expenses
-
-
-
-
Net income
3.62M
61.02M
-4.93M
-5.90M
Net profit margin
18.08%
132.98%
-27.87%
-28.45%
Earnings per share
0.04
0.06
0.01
0.18
Interest and investment income
4.14M
3.74M
3.01M
3.49M
Interest expense
-573.00K
-582.00K
-
-
Net interest expenses
3.57M
3.16M
3.01M
3.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.05M
20.41M
-5.47M
2.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps